where does the hepatic portal vein carry blood to

Introduction

The veins that drain the gastrointestinal organs parallel the major arteries that supply the foregut, midgut, and hindgut, including the celiac, superscript mesenteric, and the inferior mesenteric arteries respectively. These veins eventually convene at the portal vein, forming a single venous inflow tract into the liver. The celiac vein drains the foregut structures, including the stomach, through the second part of the duodenum. The superior mesenteric vein drains the third part of the duodenum through the initial two-thirds of the transverse colon. At length, the inferior mesenteric venous blood vessel drains the remaining one-third gear of the transverse colon through with the rectum. These veins comprehensively drain nutrients and toxins from the organic process uptake and ultimately put up approximately 75% of the colorful's blood supply, the remainder coming from the liverwort artery, at length draining into the hepatic veins and general circulation.[1][2]

Social structure and Function

The liver-colored receives 25% of the total cardiac output during each cardiac round. The hepatic portal vein receives drainage from the gallbladder, irascibility, pancreas, abide, and small and large intestines. The portal vein forms from the confluence of the superior and bush peritoneum veins, the splenic vein, vena gastrica, and pathology vein. The portal vein enters the liver within the hepatoduodenal ligament, traveling posterior to the correct arteria hepatica and the common bile duct. When the portal site vein reaches the hilum of the liver, IT divides into right and left wing branches and feeds into the liver sinusoids. This vasculature comprises the majority of the blood flow to the coloured, also as draining rear toxins and nutrients from the drained gastrointestinal tract. Stemma then empties into the indifferent vena cava (IVC). Figure 1 demonstrates normal portal blood vessel anatomy and ramate patterns, as shown by demarcation-enhanced CT.

The remaining minority 25% of pedigree flow to the liver is supplied by the proper hepatic artery. Hepatic parenchymal cells are some of the nigh richly-perfused cells in the entire human body delinquent to this blood flow. They pick up well-oxygenated blood from the liverwort arterial blood vessel and nutrient-grand blood from the splanchnic vessels via the portal blood vessel system. This blood mixes within the hepatic sinusoids. The intrahepatic and hepatic portal vein venous pressures are regulated aside portal venous sphincters. The portal branches as it enters the liver into the straight and left portal veins and then further divides. The progressively smaller branches that come from the blood vessel divisions form the hepatic portal vein venules. Subsequently the ancestry mixes within the sinusoids, it is collected within the terminal liverwort venule or centrical vein. These central veins then mix to signifier the viscus nervure, which drains the liver back to the IVC, allowing blood to take to the heart and general circulation.

There is a large volume of blood contained within the portal blood vessel organization and a similarly-large amount of blood contained within the liver. The volume of blood contained within this system affects the consistency's response to mobile loss Beaver State excess. The blood contained within the portal vein vein is crucial to the liver's functional role, including lipoprotein metastasis, drug metabolic process, and toxin clearance, as well as secretory organ homeostasis.[3][2]

Embryology

The embryology of the portal site venous system begins during the fourth workweek of gestation and continues to the twelfth week. During development, the viscus portal system is composed of the vitelline venous system in conjunction with the umbilical veins. The primitive venous scheme of the coloured begins every bit the right and left vitelline veins. O'er time, these two veins undergo selective involution involving the cranial fortune of the left vitelline vein and their anastomoses. The abaxial and cranio-ventral anastomoses produce to the main portal site vein and the left portal mineral vein, respectively.[2]

Physiological Variants

Morphology variants of the pursuit blood vessel morphologies occur in up to 35% of individuals.

• Trifurcation of the main portal vein

• The right rear branch, which arises from the main portal vein

• The right anterior branch which originates from the socialist portal vein vein

Duplication of the portal vein and non-branching portal vein variants exist as wellspring but are rare.

Congenital anomalies of the portal site blood vessel system can occur. The most common inborn anomalousness is agenesis of the left or right vena portae. This variant can pass to the development of collateral vessels of the portal blood vessel system as a result of portal hypertension. The most common of these collaterals are gastroesophageal, paraumbilical, inferior mesenteric, and splenorenal collateral vessels.[4]

Medical procedure Considerations

Knowledge of both normal and variant bod is of utmost grandness, especially for surgery. The ramous patterns of the portal venous system of rules are often assessed prior to surgery via imaging techniques. Color Doppler Ultrasound (US) is the most useful imagination technique for identifying aneurysms and/or thrombosis of the portal vein. Helical CT is a valuable tool for visualizing the branching pattern of the portal venous system. [4] Anatomical variants of portal vein's branching blueprint are intrinsic to distinguish along imaging for liver surgery to maintain perfusion to the remaining liver segments. Additionally, the physique of the portal venous circulation is significant for liver transplantation in which some the donor's venous anatomy and the receiver's anatomy requires analysis to ensure apposite donor and recipient selection.[2]

Vena portae thrombosis is a frequent occurrence in patients with hypercoagulable diseases, such As malignancy and cirrhosis, and can be a gainsay at the time of liver transplanting. Due to the increased morbidity and mortality related with this condition at the meter of organ transplant, this thrombotic state is well thought out a relative contraindication to a liver transfer.[5] Hepatic portal vein vein recanalization (PVR) and transjugular intrahepatic portosystemic shunts (TIPS) are safe options for patients with portal vein thrombosis in dire need of a liver-colored transplant.[6]

Collectible to the large amount of rip contained within the colored and flowing through the portal vein system, patients that suffer liver injuries are at raised put on the line for hemorrhagic stun and death from line loss. Transversal clamping the hepatic pedicle, known as the Pringle Maneuver, stops the blood flow to the liver and allows for better visualization of the surgical arena and aids in preventing hemodynamic crack.[7]

Clinical Meaning

Hepatic portal vein hypertension is a disease that arises when bloodline flow through the liver is compromised, and blood pressures in the vena portae rise. This disease has many complications that result from increased pressing, including muscle system varices, ascites, and hepatorenal syndrome, which contribute to the high morbidity and mortality often seen in this condition.[8] The blood flow through the liver has a organise effect on renal function via a reflex mechanism. The liver detects the sensorial afferent response via blood flow-dependent changes in the intrahepatic adenosine concentrations. The efferent response to changes in hepatic blood flow is studied by the renal harmonious nerves, causation constriction of renal vasculature and release of renal vasoconstricting molecules sequent in renal disfunction.[9] To date, the exclusively definitive treatment of hepatorenal syndrome is a liver transplanting.[10]

Additionally, if a patient is under condition for partial liver resection, portions of the portal vein can be embolized to enable hypertrophy of the remaining liver segments that quiet receive rate of flow from other segments of the vena portae venous system. In a majority of patients, portal vein embolization results in adequate liver hypertrophy to allow surgical procedure to proceed. However, should the portal vein embolization result in insufficient hypertrophy of the unexpended liver segments, hepatic vein embolization may be an option to augment the effects of portal embolization.[11]

Other medical institution consideration aforementioned is vena portae vein thrombosis, which can be pathologically acquired, as seen in cirrhosis, malignancy, liver tumors, and patients with a certainJAK2mutation. Portal vein thrombosis can present with varied symptoms, including ab pain, ischemic hepatitis, liver failure, and/or small intestine infarction. Patients generally receive treatment with anticoagulant medication. This discourse can receive further complications by the related coagulopathy often seen in these patients. The surgeon may consider a transjugular intrahepatic portosystemic shunt (TIPS) function in patients who set not improve or continue to worsen despite anticoagulation.[12][13]

Inspection Questions

Figure

Reckon 1. Standard portal fork patterns as visualized by contrast-enhanced CT tomography. Carneiro, C., Brito, J., Bilreiro, C., Barros, M., Bahia, C., Santiago de Chile, I., & Caseiro-Alves, F. (2019). All just about hepatic portal vein: a pictorial video display to (more...)

References

1.

Granger DN, Holm L, Kvietys P. The Channel Circulation: Physiology and Pathophysiology. Compr Physiol. 2015 Jul 01;5(3):1541-83. [PubMed: 26140727]

2.

Carneiro C, Brito J, Bilreiro C, Barros M, Bahia C, Capital of Chile I, Caseiro-Alves F. All about portal vein: a pictorial reveal to anatomy, variants and physiopathology. Insights Imaging. 2019 Mar 21;10(1):38. [PMC free clause: PMC6428891] [PubMed: 30900187]

3.

Lautt WW. Liverwort Circulation: Physiology and Pathophysiology. Morgan & Claypool Life Sciences; San Rafael (Calif.): 2009. [PubMed: 21452433]

4.

Gallego C, Velasco M, Marcuello P, Tejedor D, De Campo L, Friera A. Congenital and acquired anomalies of the vena portae venous system. Radiographics. 2002 Jan-Feb;22(1):141-59. [PubMed: 11796904]

5.

Thornburg B, Desai K, Hickey R, Kulik L, Ganger D, Bread maker T, Abecassis M, Lewandowski RJ, Salem R. Portal Venous blood vessel Recanalization and Transjugular Intrahepatic Portosystemic Electrical shunt Creation for Chronic Vena portae Mineral vein Thrombosis: Technical Considerations. Tech Vasc Interv Radiol. 2016 Defect;19(1):52-60. [PubMed: 26997089]

6.

Thornburg B, Desai K, Hickey R, Hohlastos E, Kulik L, Ganger D, Baker T, Abecassis M, Caicedo JC, Ladner D, Fryer J, Riaz A, Lewandowski RJ, Salem R. Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Prolonged Portal Mineral vein Thrombosis: Final Analysis of a 61-Forbearing Cohort. J Vasc Interv Radiol. 2017 Dec;28(12):1714-1721.e2. [PubMed: 29050854]

7.

Imamura H, Kokudo N, Sugawara Y, Sano K, Kaneko J, Takayama T, Makuuchi M. Pringle's maneuver and selective influx occlusion in living donor liver hepatectomy. Liver Transpl. 2004 Jun;10(6):771-8. [PubMed: 15162472]

8.

Simonetto DA, Liu M, Kamath PS. Portal High blood pressure and Related Complications: Diagnosis and Management. Mayonnaise Clin Proc. 2019 Apr;94(4):714-726. [PubMed: 30947834]

9.

Pillebout E. [Hepatorenal syndrome]. Nephrol Ther. 2014 Feb;10(1):61-8. [PubMed: 24388293]

10.

Facciorusso A, Chandar AK, Murad MH, Prokop LJ, Muscatiello N, Kamath Postscript, Singh S. Relation efficaciousness of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and mesh meta-analysis. Lance Gastroenterol Hepatol. 2017 Feb;2(2):94-102. [PubMed: 28403995]

11.

Piron L, Deshayes E, Escal L, Souche R, Herrero A, Pierredon-Foulongne Mammy, Assenat E, le Lam N, Quenet F, Guiu B. [Vena portae embolization: Present and future]. Bull Malignant neoplastic disease. 2017 May;104(5):407-416. [PubMed: 28477870]

12.

Haris M, Thachil J. Vena portae thrombosis - a primer for the general physician. Clin Med (Lond). 2017 Jun;17(3):212-219. [PMC free article: PMC6297567] [PubMed: 28572222]

13.

Basit SA, Stone CD, Lillian Gish R. Hepatic portal vein thrombosis. Clin Liver Dis. 2015 Feb;19(1):199-221. [PubMed: 25454305]

where does the hepatic portal vein carry blood to

Source: https://www.ncbi.nlm.nih.gov/books/NBK554589/

Berbagi :